ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 1448

$482K Total Retail Price of All Prescriptions

Rank: 145 out of 1448

570 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 6,690 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 565 543 1 6
CARVEDILOL 546 501 2 1
AMLODIPINE BESYLATE 502 485 3 2
LISINOPRIL 494 435 4 5
ATORVASTATIN CALCIUM 484 443 5 4
SIMVASTATIN 421 393 6 3
FUROSEMIDE 265 263 7 7
BYSTOLIC 265 262 7 32
DIOVAN 263 251 9 15
DIGOXIN 208 208 10 13
PRADAXA 185 166 11 27
SOTALOL 134 126 12 40
EXFORGE 131 131 13 80
NIASPAN 124 124 14 47
SPIRONOLACTONE 120 112 15 24
METOPROLOL TARTRATE 110 110 16 9
FLECAINIDE ACETATE 107 104 17 53
ISOSORBIDE MONONITRATE ER 106 95 18 16
CLOPIDOGREL 99 94 19 10
LOSARTAN POTASSIUM 96 87 20 11
CRESTOR 91 89 21 17
WARFARIN SODIUM 72 68 22 8
DILTIAZEM 24HR ER 70 66 23 52
VYTORIN 69 69 24 71
HYDROCHLOROTHIAZIDE 68 68 25 18
PRAVASTATIN SODIUM 67 66 26 20
DIOVAN HCT 63 57 27 29
ZETIA 62 62 28 28
PLAVIX 60 56 29 14
LANOXIN 59 59 30 178
RAMIPRIL 57 47 31 36
DILTIAZEM ER 50 50 32 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.